Solvent dependent synthesis of silver nanoparticles using Morus rubra: correlating physicochemical properties with antimicrobial and anticancer activity Authors: Alsaba H. Nadaf, Ali Abdulmawjood Mohammed, Hiba Qasim Mahmoud, Vishwajeet. V. Aherkar, Siddhaling. B. Bhairungi, Rekha. M. Ovhal, Panchsheela A. Ubale Published: 2026 ABSTRACT Silver nanoparticles (AgNPs) were successfully synthesised using Morus rubra leaf decoctions prepared using two solvent systems: aqueous (MR-AgNPs-Aq) and hydroalcoholic (MR-AgNPs-HA). The impact of solvent formulation on nanoparticle formation, structural properties, and biological activity was studied. Ultraviolet-visible (UV-vis) absorption analysis validated the synthesis of the nanoparticles through a distinctive plasmonic absorption peak around 450 nm for MR-AgNPs-Aq and in the 500 nm wavelength region for MR-AgNPs-HA, suggesting differences in particle growth and interaction with phytochemicals. FTIR analysis indicated the phytochemicals such as phenolics and flavonoids involved in nanoparticle reduction and stabilisation. Both XRD and SAED confirmed the face-centred cubic (FCC) crystal structure of silver nanoparticles. SEM and TEM analyses showed that the particles were predominantly spherical in morphology. MR-AgNPs-HA particles were smaller, around 12 nm, and more evenly sized. MR-AgNPs-Aq particles were bigger, around 17 nm, and less uniform. The synthesised AgNPs showed concentration dependent antibacterial activity. At 10 mg mL−1, the inhibition zones ranged from 7–14 mm for MR-AgNPs-Aq and 7–15 mm for MR-AgNPs-HA against the tested bacterial strains. Antifungal activity was more distinct against Candida albicans, whereas negligible inhibition was observed against Aspergillus niger. In the MTT assay, MR-AgNPs-HA showed stronger anticancer activity against MCF-7 cells, with an IC50 of 5.73 µg mL−1 compared with 54.69 µg mL−1 for MR-AgNPs-Aq. At 6.25 µg mL−1, MCF-7 cell viability was 52.82% and 68.98% for MR-AgNPs-HA and MR-AgNPs-Aq, respectively. Overall, the hydroalcoholic decoction produced nanoparticles with more favourable physicochemical characteristics and stronger biological activity than the aqueous decoction. These findings highlight the potential of the synthesised AgNPs for future biomedical applications. Introduction Nanotechnology has emerged as a fast-growing discipline with substantial implications for biomedicine, catalysis, and materials science, particularly because of the development of metal nanoparticles with unique physicochemical properties.1 Among metal nanoparticles, silver nanoparticles (AgNPs) have attracted considerable research interest. This is mainly because of their notable antibacterial, anticancer, and optical properties.2 These properties are associated with their high surface-to-mass ratio and localised surface plasmon resonance (LSPR) behaviour. Because of their distinctive optical behaviour in the visible light range, AgNPs are very useful for sensing and medical applications.3 Traditional physical and chemical methods for synthesising AgNPs often involve hazardous reagents and may have adverse environmental impacts.4 Therefore, plant-mediated synthesis has emerged as a viable and more sustainable substitute.5 Plant-derived polyphenols, including flavonoids, phenolics, botanical isoprenoids, and proteins, serve as simultaneous electron donors and colloidal stabilizers in these methods, allowing for the regulated production of nanoparticles in mild environments.6 The extraction medium and phytochemical composition of the botanical decoction have important effects on the physicochemical properties of biosynthesised nanoparticles.7 Hydroalcoholic decoctions provide a wider range of bioactive substances, resulting in variations in nucleation, growth, and size distribution, while aqueous decoctions mainly consist of polar compounds.8 These differences can influence nanoparticle stability and functionality. Morus rubra (red mulberry) constitutes an abundant reservoir of biologically active compounds, including polyphenolic flavonoids, anthocyanins,9 hydroxybenzoic acids, and hydroxycinnamic acids,10 which possess antioxidant and other biological properties.11 These compounds may also contribute to nanoparticle formation by serving simultaneously as reducing and capping/stabilising agents, which improves stability and biological activity.12 Phytochemical analysis showed the presence of major bioactive compounds in both decoctions, with MR-AgNPs-HA showing higher flavonoid content and MR-AgNPs-Aq showing higher phenolic content. These phytochemicals play an important role in nanoparticle synthesis, stabilisation, and biological activity.13 Proper characterisation is essential for understanding nanoparticle properties.14 Ultraviolet-visible (UV-vis) absorption analysis is employed to validate the generation of nanoparticles through a distinctive plasmonic absorption peak.15 FTIR helps elucidate the functional groups that participate in electron donation and stabilisation.16 XRD confirms the crystal structure and phase purity.17 SEM and TEM provide information on particle morphology, size, and aggregation.18 SAED is also used to substantiate the crystallographic phase profile of the manufactured nanoparticles.19 AgNPs exhibit broad-spectrum antimicrobial activity through various mechanisms, including membrane disruption, reactive oxygen species generation, and interference with essential cellular processes.20 Their anticancer activity has also been associated with oxidative stress,21 mitochondrial dysfunction,22 DNA damage, and apoptosis.23 Recent advances in plant-mediated silver nanoparticle synthesis have shown the successful use of a variety of plant decoction as reducing and stabilizing systems,24 with increasing interest in controlling nanoparticle size, morphology, crystallinity, stability, and biological performance.25 Within the Morus genus, different species have been explored for the synthesis of silver nanoparticles, including Morus alba (white mulberry)26 and Morus nigra (black mulberry).27 In contrast, Morus rubra (red mulberry) remains relatively underexplored as a phytochemical source for silver nanoparticle synthesis. This species contains diverse bioactive constituents, including flavonoids, phenolic compounds, anthocyanins, and other phytochemicals that contribute to nanoparticle formation and stabilisation.28 Moreover, the influence of extraction solvent on the phytochemical composition29 and, consequently, on the physicochemical and biological properties of Morus rubra-derived AgNPs remains inadequately investigated.30 A solvent selection can influence the extraction of bioactive constituents and also affect nanoparticle nucleation, growth, surface functionalization, stability, and biological activity.31 Therefore, the present study focuses on the comparative synthesis of AgNPs using aqueous and hydroalcoholic Morus rubra leaf decoction and establishes a relationship between extraction solvent, phytochemical composition, nanoparticle physicochemical characteristics, antimicrobial activity, and anticancer performance.32 In this work, silver nanoparticles (AgNPs) were synthesised using Morus rubra leaf decoctions prepared with two different solvent systems: aqueous (MR-AgNPs-Aq) and hydroalcoholic (MR-AgNPs-HA). The effect of solvent composition on nanoparticle formation, structural characteristics, and biological efficacy was systematically studied using UV-visible spectroscopy, FTIR, XRD, SEM, TEM, and SAED analyses. Experimental Fresh leaves of Morus rubra were collected from Solapur, Maharashtra, India in the month of March and properly authenticated. Silver nitrate (AgNO3) and ethanol (C2H5OH) of AR grade were used. All chemicals were purchased from Loba Chemicals. Deionized water was used throughout all experiments. Formulation of the botanical decoction Aqueous leaf decoction Fresh leaves were collected and washed thoroughly with demineralised water to remove surface contaminants and other impurities. After washing, the leaves were allowed to dry under ambient conditions and then pulverised into fine biomass. To this, 10 g of biomass was added to 150 mL of deionized water. This mixture was subjected to thermal extraction at 60 °C for 30 min with continuous stirring. The decoction was then filtered through a Whatman No. 1 paper to separate insoluble particulates. Hydroalcoholic leaf decoction For hydroalcoholic leaf decoction, 10 g of leaf biomass was suspended in 150 mL of ethanol – deionized water at a 1 : 1 ratio. The mixture was first kept in a dark chamber for 12 h for maceration. This mixture was subjected to thermal extraction at 60 °C for 30 min with continuous stirring. The decoction was then filtered through a Whatman No. 1 paper to separate insoluble particulates. Phytochemical analysis Qualitative evaluation of phytochemical constituents Qualitative evaluation of phytochemical constituents in aqueous and hydroalcoholic Morus rubra decoction was performed using standard protocols to identify alkaloids, carbohydrates, reducing sugars, glycosides, cardiac glycosides, proteins, flavonoids, phenolic compounds, tannins, and saponins present. Specific tests such as Dragendorff's test for alkaloids, Molisch's test for carbohydrates, Benedict's test for reducing sugars, ferric chloride test for phenolics, and foam test for saponins were performed. Total flavonoid content (TFC) The total flavonoids content was quantified via the aluminium chloride spectrophotometric technique. Briefly, the decoction was treated with sodium nitrite, aluminium chloride, followed by the addition of sodium hydroxide to terminate the reaction, wherein the resulting spectral absorbance was quantified at 510 nm utilizing a UV-vis spectrophotometric system. Quercetin was used as standard, then results were expressed as mg QE g−1 of decoction. Total phenolic content (TPC) Total phenolic concentration was estimated by the Folin–Ciocalteu assay. After reacting the decoction with sodium carbonate and Folin–Ciocalteu reagent, absorbance was measured at 765 nm. The results were given as mg GAE g−1 of decoction, with gallic acid serving as the standard. Synthesis of silver nanoparticles First, a 10 mM AgNO3 solution was prepared in 100 mL deionised water. Next, the silver nitrate solution was gradually added dropwise to 50 mL of botanical decoction while stirring continuously. The addition was continued to 90 min at 65 °C. A shift in colour from pale yellow to brown indicated the development of silver nanoparticles. Two types of nanoparticles were synthesised: MR-AgNPs-Aq was prepared using the aqueous decoction and MR-AgNPs-HA was prepared using the hydroalcoholic decoction. Structural and optical characterisation of silver nanomaterials The synthesised AgNPs were characterised using several analytical techniques. Initially, ultraviolet-visible (UV-vis) absorption analysis was performed to verify nanoparticle formation and assess the reduction of Ag+ ions by decoction of Morus rubra leaves. A double-beam Shimadzu UV-2600i spectrophotometer was used for this and scanning was done in the range of 200–1000 nm. FTIR analysis was performed using a Bruker Alpha II with the KBr pellet technique. This helped to identify functional groups such as phenols, flavonoids, and proteins responsible for reduction, capping, and stabilisation of nanoparticles. To evaluate the structural phases and crystallinity of the synthesised AgNPs, XRD analysis was performed. The data were collected on an Ultima IV instrument (Rigaku Corporation) utilizing a Cu K-α X-ray source (λ = 1.5406 Å). Field emission scanning electron microscopy (FESEM; JEOL IT800HL) was employed to examine surface topography. The specimen preparation involved mounting the dried silver nanoparticles on carbon tape followed by gold sputter-coating. Furthermore, high-resolution transmission electron microscopy (HRTEM) and selected area electron diffraction (SAED) patterns were acquired on a JEOL JEM-2100 instrument. These analyses were performed to determine particle size, morphology, and lattice structure. For these analyses samples were prepared by spreading nanoparticles in demineralised water and then ultrasonicated to avoid aggregation. The dispersion was then placed onto a carbon-coated copper grid and allowed to dry at ambient temperature. TEM images were analysed employing ImageJ software to get the particle size distribution. SAED patterns were also obtained to further confirm the crystal structure of the synthesised AgNPs. Biological activities Antimicrobial efficacy The antibacterial efficacy of the synthesised AgNPs was examined using the agar well diffusion assay. Four bacterial strains were selected for this study: S. aureus (ATCC 6538) and B. subtilis (ATCC 6051) representing Gram-positive bacteria, and E. coli (ATCC 8739) and P. aeruginosa (ATCC 27857) representing Gram-negative bacteria. Fresh cultures were prepared. All suspensions of bacterial cells were carefully adjusted to 0.5 McFarland standard so that uniform microbial density could be maintained across all experimental plates. Sterile Antibiotic Assay Medium No. 19 was poured into Petri plates after mixing with bacterial suspension, and an agar depth of 3–4 mm was maintained throughout. Wells of 6 mm diameter were punched after solidification. At concentrations of 5 and 10 mg mL−1, both MR-AgNPs-Aq and MR-AgNPs-HA were evaluated. Streptomycin (1 mg mL−1) was used as positive control whereas DMSO served as the negative control. Into each well, 100 µL of sample was carefully introduced. Pre-diffusion was allowed at 2–8 °C for 15–20 minutes. The plates were then incubated for 24 to 48 h at 30–35 °C. The inhibitory zones were measured in millimetres. The results are in Table 4 and zone images are shown in Fig. 7.1–7.4. For antifungal testing, the same agar-well diffusion method was followed against C. albicans (ATCC 10231) and A. niger (ATCC 16404). To standardize turbidity, freshly prepared fungal cultures were adjusted before use. The medium and plate preparation were the same as antibacterial testing. At 5 and 10 mg mL−1, both test samples were again evaluated. Fluconazole (1 mg mL−1) was used as the standard antifungal agent and DMSO was negative control. Into the wells, 100 µL of each solution was carefully introduced. After pre-diffusion at 2–8 °C, plates were incubated for 24–48 h at 20–25 °C. Zones of inhibition were measured in millimetres after incubation, and the results are summarized in Table 5. Representative antifungal images are shown in Fig. 7.5 and 7.6. Antiproliferative activity against MCF-7 cells In vitro anticancer potential was assessed by the MTT assay using MCF-7 human breast cancer cells. Cells were obtained from NCCS, Pune and maintained in MEM with 10% FBS and antibiotic-antimycotic supplements. Cells were cultured at a density of 1 × 104 cells per mL under standard incubation conditions (37 °C, 5% CO2, humidified atmosphere). Subsequently, the cells were seeded into 96-well plates and treated with varying concentrations (6.25–100 µg mL−1). Control wells received 0.2% DMSO in PBS. After 24 h, the culture medium was discarded. Fresh 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide solution (5 mg mL−1) was then added, and the plates were further incubated to allow formazan crystals formation. After dissolving the formazan crystals in DMSO, optical density was measured at 570 nm using an ELISA plate reader. The percentage of viable cells relative to the control was calculated, and IC50 values were determined. Cytotoxicity assessment on normal cell line (L929) Cytotoxicity on Normal Cell Line (L929): to assess whether the synthesised nanoparticles cause toxicity normal cells, cytotoxicity was evaluated using the L929 mouse connective tissue cell line. The same MTT protocol was followed. In DMEM medium with 10% FBS and antibiotic supplements, cells were cultured at 37 °C with 5% CO2. Into 96-well plates, cells were seeded and exposed to concentrations from 100 to 6.25 µg mL−1. MTT reagent was added after 24 h of incubation and formazan crystals formed by viable cells were dissolved in DMSO. Absorbance was recorded at 570 nm and cell viability percentage was calculated with respect to control (untreated) cells (Table 1). Table 1Comparison of physicochemical and biological properties of selected Morus-derived silver nanoparticlesPlant sourceExtraction systemParticle size (nm)MCF-7 IC50 (µg mL−1)Biological activitiesReferences Morus alba Aqueous20–44.518Antibacterial and anticancer 27 Morus nigra Aqueous170.17 ± 12.6596.9Antioxidant, antimicrobial and anticancer 39 Morus rubra Aqueous1754.69Antibacterial, antifungal and anticancerPresent study Morus rubra Hydroalcoholic125.73Enhanced antibacterial, antifungal and anticancer activityPresent study Comparison of physicochemical and biological properties of selected Morus-derived silver nanoparticles Results and discussion Phytochemical analysis Qualitative evaluation of phytochemical constituents Qualitative evaluation of phytochemical constituents Table 2 revealed the presence of key bioactive constituents in both decoctions. Alkaloids, carbohydrates, reactive saccharides, glycosides, cardiotonic glycosides, along with saponins were consistently identified in both aqueous and hydroalcoholic decoctions. Proteins and tannins were absent in both samples. Predominantly, polyphenolic flavonoids and phenolic compounds were detected only in the hydroalcoholic decoction, indicating greater extraction efficiency of these bioactive compounds in this solvent system. Table 2Qualitative evaluation of phytochemical constituents in aqueous and hydroalcoholic decoctionPhytoconstituentTest performedAqueous decoctionHydroalcoholic decoctionAlkaloidsDragendorff's test++CarbohydratesMolisch's test++Reactive saccharidesBenedict's test++SaponinsFoam test++FlavonoidsLead acetate test−+PhenolicsFerric chloride test−+ProteinsBiuret test−−TanninsBraymer's test−− Qualitative evaluation of phytochemical constituents in aqueous and hydroalcoholic decoction Quantitative analysis The total flavonoid content (TFC), presented in Table 3, Fig. 1b and d, was higher concentration in hydroalcoholic decoction (0.699 ± 0.035 mg QE g−1) than in aqueous decoction (0.599 ± 0.032 mg QE g−1), indicating a greater abundance of flavonoid compounds in the hydroalcoholic decoction. In contrast, the total phenolic content (TPC) Table 3, Fig. 1a and c, was higher in aqueous decoction (0.513 ± 0.015 mg GAE g−1) than hydroalcoholic decoction (0.346 ± 0.030 mg GAE g−1). Table 3Total phenolic and flavonoid content of aqueous and hydroalcoholic decoctionSampleTotal phenolic content (mg GAE g−1)Total flavonoid content (mg QE g−1)Aqueous0.5130.599Hydroalcoholic0.3460.699 Total phenolic and flavonoid content of aqueous and hydroalcoholic decoction (a) Total phenolic content (TPC) of Morus rubra leaf decoction expressed as mg GAE g−1. (b) Total flavonoid content (TFC) of Morus rubra leaf decoction expressed as mg QE g−1. (c) Standard calibration curve of Gallic acid for the estimation of total phenolic content (TPC) (d) standard calibration curve of Quercetin for the estimation of total flavonoid content (TFC). The higher flavonoid content in hydroalcoholic decoction suggests greater reducing and stabilizing ability during nanoparticle synthesis, which contribute to improved nanoparticle uniformity and biological activity. In contrast, the higher phenolic content in aqueous decoction may contribute to its antioxidant potential, highlighting the complementary roles of different phytochemicals in nanoparticle formation and biological activity. Ultraviolet-visible (UV-vis) absorption analysis Ultraviolet-visible (UV-vis) absorption analysis of AgNO3 solution, plant decoction, and synthesised nanoparticles are presented in Fig. 2a–c. The AgNO3 solution Fig. 2a showed an absorption band at around 300 nm. This absorption was attributed to Ag+ ions. No distinctive plasmonic absorption peak was observed. The aqueous and hydroalcoholic decoction Fig. 2b and c showed absorption in the 200–350 nm range. This was attributed of π–π transitions of phytochemicals such as phenolics and flavonoids, which are known to participate in nanoparticle synthesis. After the reaction, the appearance of a distinctive surface plasmon resonance (SPR) absorption band in the visible region confirmed the formation of silver nanoparticles.33 MR-AgNPs-Aq Fig. 2d showed a distinctive plasmonic absorption peak centred at around 450 nm, which is typical of spherical silver nanoparticles within the nanoscale range.34 The shape of this peak suggested the presence of nanoparticles with moderate size distribution. In contrast, MR-AgNPs-HA Fig. 2e showed a well-defined and more intense plasmonic absorption peak at around 500 nm.34 The red shift of the plasmonic absorption peak may be related to differences in particle size, morphology, and local dielectric environment created by surrounding phytochemicals.35 The sharper and better-defined peak of MR-AgNPs-HA suggested more uniform nanoparticle formation, indicating that biomolecule interaction was more effective in the hydroalcoholic system.36 The presence of phenolic and flavonoid compounds in the decoction supports their possible role as reducing agents in the conversion of ionic silver (Ag+) to metallic (Ag0), which is reflected in the characteristic plasmonic absorption peaks observed in the UV-vis spectra.37 Overall, the appearance of distinctive plasmonic absorption peaks in both samples confirmed that ionic silver (Ag+) was successfully converted into metallic silver (Ag0) nanoparticles. These results gave the first clear evidence of nanoparticle formation, which was then further confirmed by structural and morphological characterisation techniques. Ultraviolet-visible (UV-vis) absorption analysis of Morus rubra leaf decoctions and corresponding silver nanoparticles: (a) AgNO3 solution, (b) aqueous decoction, (c) hydroalcoholic decoction, (d) MR-AgNPs-Aq, and (e) MR-AgNPs-HA, showing a distinctive plasmonic absorption peak confirming nanoparticle synthesis. FTIR analysis The FTIR analysis of Morus rubra decoctions and the synthesised nanoparticles are shown in Fig. 3a and b. The aqueous decoction indicated prominent O–H stretching bands at ∼3374 cm−1, along with bands at ∼2922–2850 cm−1 (C–H stretching), ∼1742 cm−1 (C Created by potrace 1.16, written by Peter Selinger 2001-2019 O), ∼1587 cm−1 (aromatic CC), and ∼1274–1044 cm−1 (C–O stretching).38 Similarly, the hydroalcoholic decoction exhibited bands at ∼3340 cm−1 (O–H), ∼2925–2854 cm−1 (C–H), ∼1585 cm−1 (aromatic), and ∼1398–1069 cm−1 (C–H bending and C–O stretching), consistent with the presence of phenolic and flavonoid compounds. Changes in band positions and intensities were observed after nanoparticle formation, shifts and changes in intensity were observed in Fig. 3c and d for MR-AgNPs-Aq and MR-AgNPs-HA, indicating the contribution of these organic functional groups to the reduction and stabilisation processes.39 MR-AgNPs-Aq showed bands at ∼2928 cm−1 (C–H), ∼1785 cm−1 (CO), ∼1609 cm−1 (CC), and ∼1050 cm−1 (C–O), along with a low-frequency band near ∼500 cm−1 attributed to Ag–O interactions. MR-AgNPs-HA exhibited bands at ∼3040 cm−1 (O–H), ∼2929 cm−1 (C–H), ∼1814 cm−1 (CO), ∼1386 cm−1 (C–H bending), and ∼1235 cm−1 (C–O). The observed band shifts indicate the involvement of phytoconstituents in the reduction mechanism of Ag+ ions and capping of nanoparticles.40 These results are consistent with phytochemical analysis, confirming that bioactive functional moieties including hydroxyl and carbonyl groups, associated with flavonoids and phenolics, play a significant role in bio-reduction of Ag+ ions and capping.41 Overall, the spectra suggest stronger interactions between phytochemical constituents and MR-AgNPs-HA, which may contribute to nanoparticle stability and uniformity. FTIR spectra of Morus rubra leaf decoction and corresponding silver nanoparticles: (a) aqueous decoction, (b) hydroalcoholic decoction, (c) MR-AgNPs-Aq, and (d) MR-AgNPs-HA, showing organic functional groups that play significant role in nanoparticle synthesis and capping. XRD analysis The XRD patterns of the synthesised nanoparticles represented in Fig. 4a and b. Both MR-AgNPs-Aq and MR-AgNPs-HA exhibited distinct diffraction peaks corresponding to the (111), (200), (220), and (311) planes of FCC crystalline silver, matching the standard JCPDS card (No. 04-0783), confirming the formation of crystalline metallic Ag0 nanoparticles.42 The most intense peak corresponded to the (111) plane, indicating dominant crystal orientation.43 The diffraction peaks observed for MR-AgNPs-HA were comparatively sharper and more intense than those of MR-AgNPs-Aq, indicating improved crystallinity and structural ordering. The crystallite sizes calculated using the Scherrer equation were in the nanoscale range, consistent with nanoparticle formation. The absence of additional diffraction peaks associated with silver oxide or other crystalline impurities suggests the phase purity of the synthesised nanoparticles.44 The crystalline nature of the nanoparticles may be related to phytochemical-mediated nucleation and growth processes during synthesis. The observed crystallinity supports the optical confirmation of nanoparticle synthesis and establishes the formation of well-defined metallic silver nanoparticles. XRD analysis of silver nanoparticles synthesised using Morus rubra decoctions: (a) MR-AgNPs-Aq and (b) MR-AgNPs-HA, showing characteristic diffraction peaks corresponding to FCC crystalline silver. FESEM analysis FESEM images of MR-AgNPs-Aq and MR-AgNPs-HA are shown in Fig. 5a and b. Both samples showed mostly spherical silver nanoparticles within the nanoscale range. FESEM analysis MR-AgNPs-Aq Fig. 5a, revealed aggregated structures with apparent dimensions of approximately 20–60 nm.45 This may attributed to weaker stabilisation resulting from a limited phytochemical capping in the aqueous system.46 MR-AgNPs-HA Fig. 5b, showed more uniform and densely packed spherical nanoparticles, suggesting the improved control over nucleation and growth because of stronger phytochemical interactions in the hydroalcoholic system.47 Some aggregation was also observed in both samples but this was thought to be because of interparticle interactions during sample drying and not because of poor colloidal stability.48 The improved morphology and size distribution observed in MR-AgNPs-HA can be related to higher flavonoid content, which increases nanoparticle capping and stabilisation.49 The improved antimicrobial and anticancer activity of MR-AgNPs-HA may be attributed to its higher flavonoid content, as flavonoids are known to influence nanoparticle interactions with microbial and cancer cells.50 Overall, the morphology and size distribution of both samples matched well with their structural data. MR-AgNPs-HA clearly showed better uniformity and more controlled growth compared to MR-AgNPs-Aq. The spherical shape of both nanoparticle types also supports their enhanced surface reactivity and better biological performance.51 The clustering observed in the FESEM images may be related to interparticle aggregation during drying and sample preparation. In contrast, the samples used for HRTEM were dispersed and ultrasonicated before analysis, which facilitated the dispersion of loosely associated nanoparticles aggregates. Therefore, the clustered structures observed by FESEM and the separated nanoparticles observed by HRTEM represent complementary morphological observations rather than contradictory results. FESEM images of silver nanoparticles synthesised via Morus rubra leaf decoctions: (a) MR-AgNPs-Aq and (b) MR-AgNPs-HA, illustrating nanoparticle morphology, size distribution, and surface characteristics. HRTEM and SAED HRTEM images of MR-AgNPs-Aq and MR-AgNPs-HA Fig. 6a and b confirmed the formation of predominantly spherical nanoparticles with nanoscale dimensions. MR-AgNPs-Aq Fig. 6a, showed particle sizes of around 9 to 25 nm (average 17 nm) with moderate polydispersity, whereas MR-AgNPs-HA Fig. 6b, showed smaller particles, ranging from 6–16 nm (average 12 nm) and more uniformly distributed nanoparticles, indicating improved control over nucleation and growth.52 HRTEM and SAED patterns of silver nanoparticles: (a and c) MR-AgNPs-Aq and (b, d) MR-AgNPs-HA, showing particle size, lattice fringes, and crystalline structure. The smaller individual particles observed by HRTEM are consistent with the presence of aggregated structures observed by FESEM, as HRTEM allows the primary nanoparticles within these aggregates to be visualized separately. The SAED patterns for both materials in Fig. 6c and d displayed distinct concentric rings corresponding to the (111), (200), (220), and (311) planes of FCC crystalline silver, which confirmed the crystalline structure of the nanoparticles.53 Sharper and more defined rings were observed for MR-AgNPs-HA Fig. 6d which indicates higher crystallinity and better structural ordering compared with to MR-AgNPs-Aq Fig. 6c. The observed size, morphology, and crystallinity are consistent with the overall structural characteristics of the samples, confirming that MR-AgNPs-HA exhibits superior uniformity, smaller particle size, and enhanced crystallinity.54 Biological activities Antimicrobial efficacy The present study demonstrates that the synthesised AgNPs showed measurable antimicrobial activity against both bacterial and fungal strains and this activity was clearly concentration-dependent. The antibacterial results (Table 4, Fig. 7a and b) showed that both samples produced moderate zones of inhibition and these zones increased at higher concentrations. This type of concentration-dependent behaviour has been reported before for silver nanoparticles, where higher nanoparticle concentrations may result in greater interaction with microbial cells and stronger antimicrobial effect. Different bacterial strains showed different levels of susceptibility. This may be due to differences in their cell wall structures. Gram positive bacteria like B. subtilis have a dense peptidoglycan wall which may facilitate nanoparticle interaction. Gram negative bacteria like E. coli have an external membrane that may limit nanoparticle penetration. But good inhibition was still seen against P. aeruginosa, which suggests that silver nanoparticles may overcome such barriers because of their small particle size and high reactive surface area.55 The antimicrobial mechanism of plant-mediated silver nanoparticles involves different pathways. They produce oxidative radicals which cause destructive pathways driven by cell envelope permeabilization combined with oxidative stress. Silver ions released from nanoparticles also interact with sulphur-containing proteins and DNA, which leads to enzyme inactivation and stops replication. Collectively, these effects can disrupt metabolic pathways and ultimately cause cellular damage and microbial death. The high specific surface area of nanoparticles facilitates the affinity towards microbial cells.56 MR-AgNPs-HA showed better antibacterial performance at higher concentrations, and this may be related to the hydroalcoholic decoction containing higher proportions of certain phytochemicals like flavonoids and phenolics that improve nanoparticle stability and bioactivity through synergistic effects.57 The antifungal results (Table 5, Fig. 7.5 and 7.6) demonstrated that the synthesised AgNps demonstrated effective antifungal activity against C. albicans. The observed activity shows the strong interaction between silver nanoparticles and yeast cell structures, leading to efficient inhibition. In comparison, A. niger is a filamentous fungus and has a thick multilayered cell wall that gives more resistance. Comparable findings have been reported in previous studies involving biosynthesised AgNPs.58 The antifungal mechanism mainly involves disruption of membrane integrity, interaction with ergosterol, and induction of oxidative stress, all of which lead to leakage of intracellular contents and disrupt essential metabolic processes.59 The very low activity against A. niger suggests that more optimisation is needed for nanoparticle size and concentration for better activity against resistant fungal strains.60 Overall, the results demonstrate antimicrobial activity of biosynthesised AgNPs, the activity varying according to microbial strains and concentration. Although their activity was lower than standard drugs, their plant-mediated synthesis and versatile characteristics make them concentration-dependent promising for future investigation. Further studies focusing on optimisation and in vivo evaluation are required to fully establish their clinical potential. Table 4Antibacterial efficacy of silver nanoparticles synthesised via Morus rubra leaf decoction (MR-AgNPs-Aq and MR-AgNPs-HA) against selected bacterial strains (S. aureus, E. coli, P. aeruginosa, and B. subtilis), expressed as zones of inhibition (mm)Sr. NoSampleConc. mg mL−1 S. aureus E. coli P. aeruginosa B. subtilis 1Standard streptomycin1323436382MR-AgNPs Aq50204101210090714143MR-AgNPs HA5010404121015071514 Antibacterial efficacy of silver nanoparticles synthesised via Morus rubra leaf decoction (MR-AgNPs-Aq and MR-AgNPs-HA) against selected bacterial strains (S. aureus, E. coli, P. aeruginosa, and B. subtilis), expressed as zones of inhibition (mm) Antimicrobial efficacy of silver nanoparticles synthesised via Morus rubra leaf decoction against selected bacterial strains: (a) MR-AgNPs-Aq and (b) MR-AgNPs-HA showing zones of inhibition against S. aureus, E. coli, P. aeruginosa, B. subtilis, C. albicans and A. niger. Table 5Antifungal efficacy of silver nanoparticles synthesised via Morus rubra leaf decoction (MR-AgNPs-Aq and MR-AgNPs-HA) against selected fungal strains (C. albicans and A. niger), expressed as zones of inhibition (mm)Sr. No.SampleConc. mg mL−1Zone of inhibition (mm) C. albicansZone of inhibition (mm) A. niger1Standard fluconazole136302MR-AgNPs Aq522011025023MR-AgNPs HA52301102702 Antifungal efficacy of silver nanoparticles synthesised via Morus rubra leaf decoction (MR-AgNPs-Aq and MR-AgNPs-HA) against selected fungal strains (C. albicans and A. niger), expressed as zones of inhibition (mm) Antiproliferative activity against MCF-7 cells Anticancer and cytotoxic activity of MR-AgNPs-Aq and MR-AgNPsHA were evaluated using the MTT assay. MCF-7 human breast cancer cell line and L929 normal fibroblast cell line were used for this purpose. Results are presented in Tables 6,7, Fig. 8, 9 and 10. Both samples showed a clear concentration-dependent response in both cell lines, which is similar to what has been reported before for nanoparticle-mediated cytotoxicity. In the case of MCF-7 cancer cells, both samples showed concentration-dependent cytotoxic activity.61 Cell viability decreased progressively as concentration was increased. MR-AgNPs-Aq reduced cell proliferation from 68.98% at 6.25 µg mL−1 to 40.42% at 100 µg mL−1. MR-AgNPs-HA showed a stronger effect, reducing viability from 52.82% to 33.88% over the same concentration range. IC50 values were also calculated. MR-AgNPs-HA gave a much lower IC50 of 5.73 µg mL−1 compared to MR-AgNPs-Aq which had IC50 of 54.69 µg mL−1, indicating that MR-AgNPs-HA was much more potent against cancer cells. The enhanced anticancer activity of MR-AgNPs-HA may be due to smaller particle size, larger surface area, and better phytochemical capping due to hydroalcoholic extraction.62 These properties may facilitate cellular uptake and interaction with intracellular targets, potentially contributing to increased cytotoxicity in cancer cells. The mechanism by which nanoparticles induce cell death is by generating reactive oxygen species, causing mitochondrial dysfunction, and activating apoptosis pathways, which collectively contribute to programmed cell death.63 When the normal L929 cells were evaluated, both samples showed lower toxicity than that observed in cancer cells. MR-AgNPs-Aq showed cell viability ranging from 67.45% at 6.25 µg mL−1 to 52.33% at 100 µg mL−1. MR-AgNPs-HA showed higher viability values ranging from 71.23% to 57.10% across the same concentrations. This clearly showed that MR-AgNPs-HA was less harmful to normal cells than MR-AgNPs-Aq. But it should be noted that neither sample kept cell viability above 75%, which means both samples still showed moderate toxicity under tested conditions. When cancer and normal cell results were compared, an interesting observation was seen. Both samples, and especially MR-AgNPs-HA, showed higher toxicity towards cancer cells while normal cells survived better. This selective behaviour was probably because cancer cells have a higher metabolic rate and are more sensitive to oxidative stress, making them more vulnerable to nanoparticle damage.64 Normal cells, on the other hand, have stronger antioxidant defence mechanisms which may help them tolerate nanoparticle exposure better. Overall, MR-AgNPs-HA was showed greater anticancer activity and relatively higher viability of L929 cells than MR-AgNPs-Ag. Its higher anticancer efficacy combined with lower toxicity to normal cells suggests that it may warrant further investigation for potential biomedical applications. But more optimisation, mechanistic studies, and in vivo work is still needed to fully confirm its therapeutic potential and safety. Table 6Cytotoxicity in MCF-7 cell line and L929 cell lineConc. (µg mL−1)MCF-7 cell lineL929 cell lineCell viability (%) MR-AgNPs-AqCell viability (%) MR-AgNPs-HACell viability (%) MR-AgNPs-AqCell viability (%) MR-AgNPs-HA6.2568.9852.8267.4571.2312.564.2847.6162.8169.932558.5145.1857.1067.015045.1840.4252.7863.7110040.4233.8852.3357.10 Cytotoxicity in MCF-7 cell line and L929 cell line Table 7IC50 valuesSampleIC50 (µg mL−1) – MCF-7MR-AgNPs-Aq54.69MR-AgNPs-HA5.73 IC50 values Dose-dependent cytotoxic effect of MR-AgNPs on (a) MCF-7 cell line and (b) L929 cell line evaluated by MTT assay. Microscopic analysis of MCF-7 breast cancer cell morphology under different treatment conditions: (a) control (b) standard drug (SD) treated cells (c) MR-AgNPs-Aq treated cells (d) MR-AgNPs-HA treated cells. Microscopic analysis of normal cell line L929 cell morphology under different treatment conditions: (a) control (b) MR-AgNPs-Aq treated cells (c) MR-AgNPs-HA treated cells. Conclusion The present study demonstrated the successful synthesis of silver nanoparticles using aqueous and hydroalcoholic Morus rubra leaf decoction. The synthesised AgNPs were characterised by UV-vis, FTIR, XRD, FESEM, HRTEM, and SAED techniques. Both systems produced crystalline silver nanoparticles with predominantly spherical to quasi-spherical morphology. HRTEM analysis showed an average particle size of approximately 17 nm for MR-AgNPs-Aq and 12 nm for MR-AgNPs-HA. The hydroalcoholic system produced relatively smaller and more uniformly distributed primary nanoparticles with comparatively higher crystallinity. The synthesised AgNPs showed concentration-dependent antimicrobial activity, with MR-AgNPs-HA demonstrating stronger activity against the tested bacterial and fungal strains. The MR-AgNPs-HA also showed stronger anticancer activity against MCF-7 cells, with an IC50 value of 5.73 µg mL−1 compared with 54.69 µg mL−1 for MR-AgNPs-Aq. Thus, among the two extraction systems investigated, the hydroalcoholic decoction produced AgNPs with more favourable physicochemical characteristics and biological activities. The main significance of this study is the demonstration that extraction-solvent selection can influence the characteristics and biological performance of Morus rubra-derived AgNPs. The hydroalcoholic system therefore represents a promising approach for obtaining smaller AgNPs with enhanced biological activity under the conditions investigated. However, the present findings are based on in vitro studies and should not be interpreted as evidence of therapeutic efficacy or safety. Future studies should focus on optimizing the extraction and nanoparticle synthesis conditions to further control particle size, aggregation, surface chemistry, and stability. Mechanistic studies should also be performed to clarify the contribution of phytochemicals and reactive oxygen species to the observed antimicrobial and anticancer activities. Long-term stability studies, detailed toxicity evaluation, and in vivo investigations will be required to further assess biological safety and therapeutic potential of the Morus rubra-derived AgNPs. Further studies may also explore the incorporation of the optimized AgNPs into suitable delivery or coating systems for potential biomedical applications. Conflicts of interest There are no conflicts to declare.